Press release from Companies: Positive results from the Phase II study of uTRACE in brain cancer presented at the World Molecular Imaging Congress (WMIC) 2023 in Prague

Press release from Companies: Curasight to present at HC Andersen Capital and at HC Andersen Life Science seminar

Reports: Interim Report January – June 2023

Press release from Companies: Positive results in uPAR-PET/MR Phase II study in brain cancer

Press release from Companies: Curasight A/S reports positive preclinical results with uTREAT[®] in aggressive brain cancer (glioblastoma)

Press release from Companies: Curasight to present at HC Andersen Capital and Økonomisk Ugebrev

Reports: Interim report Q1 2023

Press release from Companies: Curasight and Curium announce global partnership for uTRACE[®] in prostate cancer

Press release from Companies: Resolutions of the Annual General Meeting of Curasight A/S

Press release from Companies: Notice of Annual General Meeting 2023

Press release from Companies: Annual Report for the fiscal year 2022

Reports: Year-end report October - December 2022